MB
Mahadi Baig
Hematology & Oncology
Credentials: ·
History
- 2012–2015
Hematology and Medical Oncology

- 2001–2005
Medical School
Research
Amivantamab plus Lazertinib in Previously Untreated EGFR-Mutated Advanced NSCLC
New England Journal of Medicine · 2024 · 409 citations
Journal of Clinical Oncology · 2024 · 138 citations
Overall Survival with Amivantamab-Lazertinib in EGFR-Mutated Advanced NSCLC
New England Journal of Medicine · 2025 · 114 citations

9 papers
- AS
8 papers
- RK
8 papers
- TA
7 papers

6 papers
- DN
5 papers
- EY
4 papers

4 papers


